Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line
Journal: Molecular Biology Research Communications (Vol.12, No. 4)Publication Date: 2023.12.01
Authors : Aigul kh. Valiullina; Ekaterina A. Zmievskaya; Irina A. Ganeeva; Margarita N. Zhuravleva; Ekaterina E. Garanina; Albert A. Rizvanov; Alexey V. Petukhov; Emil R. Bulatov;
Page : 139-148
Keywords : Breast cancer; MCF-7; CAR-T; Immunotherapy; Solid tumor;
Abstract
The most often diagnosed and fatal malignancy in women is breast cancer. The International Agency for Research on Cancer (IARC) estimates that there are 2.26 million new cases of cancer in 2020. Adoptive cell therapy using T cells with chimeric antigen receptor shows potential for the treatment of solid tumors, such as breast cancer. In this work the effectiveness of CAR-T cells against monolayer and three-dimensional bioprinted tumor-like structures made of modified MCF-7 breast cancer cells was assessed. The cytokine profile of supernatants after co-cultivation of MCF-7 tumor cell models with CAR-T cells was also measured to reveal the inflammatory background associated with this interaction.
Other Latest Articles
- Genetic association between rs1695 in glutathione S-transferase P1 and risk of periodontitis: a pilot study
- Rapidly Growing Ovarian Granulosa Cell Tumor Following Complete Debulking for Suspected Ovarian Cancer with Histopathology Result of Benign Ovarian Cyst
- Genotype AA of ACE2 G8790A (rs2285666) Has Protective Potential Against COVID-19 Disease Severity
- Decreased Follistatin Levels as a Risk of Acute Sarcopenia Marker in Elderly
- Serum Copper, Iron, and Total Iron Binding Capacity in Hypothyroidism: A Case Control Study
Last modified: 2023-11-29 14:45:14